Transplantation of murine bone marrow or human CD34+ cord blood cells transduced with CEP110-FGFR1 produced AML in the recipient mice [347], further supporting the role of CEP110-FGFR1 as an oncogenic driver. This evidence concerns the gene FGFR1 and acute myeloid leukemia.